Tech Company Financing Transactions
Lumen Bioscience Funding Round
Lumen Bioscience, operating out of Seattle, received $13 million in funding from Avista, Bioeconomy Capital and private investors.
Transaction Overview
Company Name
Announced On
12/6/2017
Transaction Type
Venture Equity
Amount
$13,000,000
Round
Undisclosed
Investors
Avista (Lead Investor)
Bioeconomy Capital (Lead Investor)
Proceeds Purpose
These funds will allow our research team to build out the complete set of microbiology tools and methods needed to unlock our platform's vast commercial potential.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1441 North 34th St. 300
Seattle, WA 98103
USA
Seattle, WA 98103
USA
Phone
Website
Email Address
Not Recorded
Overview
Lumen Bioscience is a Seattle-based synthetic biology company focused on the development of the blue-green algae Spirulina as an industrial scale production platform.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Brian Finrow
Chief Financial Officer
Donald Schlosser
Chief Scientific Officer
James Roberts
VP - Manufacturing
Craig Behnke
Browse more venture capital transactions:
Prev: 12/6/2017: VirtualHealth venture capital transaction
Next: 12/6/2017: Pilotworks venture capital transaction
Share this article
Where The Data Comes From
We record tech company VC transactions. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs